|
BCL10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34390004574914E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19950000049474E-07 |
| Normal-vs-Stage2 |
1.52350000393042E-08 |
| Normal-vs-Stage3 |
6.03359999962194E-07 |
| Normal-vs-Stage4 |
1.34520000028004E-07 |
| Stage1-vs-Stage2 |
8.918200E-03 |
| Stage1-vs-Stage3 |
3.854600E-01 |
| Stage1-vs-Stage4 |
1.376580E-01 |
| Stage2-vs-Stage3 |
8.209600E-02 |
| Stage2-vs-Stage4 |
3.024800E-01 |
| Stage3-vs-Stage4 |
4.682000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.18169999960583E-07 |
| Normal-vs-AfricanAmerican |
8.798800E-04 |
| Normal-vs-Asian |
4.14859999997574E-06 |
| Caucasian-vs-AfricanAmerican |
7.777200E-01 |
| Caucasian-vs-Asian |
4.662200E-01 |
| AfricanAmerican-vs-Asian |
8.659200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.74719999871343E-08 |
| Normal-vs-Female |
1.31459999552774E-08 |
| Male-vs-Female |
5.493000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.69780000000208E-05 |
| Normal-vs-Age(41-60Yrs) |
5.67140001628275E-10 |
| Normal-vs-Age(61-80Yrs) |
2.30759999997332E-09 |
| Normal-vs-Age(81-100Yrs) |
1.187040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.747500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.357600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.552000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.615410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.972600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.751570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.018800E-01 |
| Classical-VS-Follicular |
4.46299663892091E-11 |
| Classical-VS-Other |
2.869800E-01 |
| Classical-VS-Normal |
4.51280000002274E-06 |
| Tall-VS-Follicular |
7.770600E-04 |
| Tall-VS-Other |
4.716400E-01 |
| Tall-VS-Normal |
2.901600E-03 |
| Follicular-VS-Other |
2.694200E-01 |
| Follicular-VS-Normal |
1.6574519534629E-12 |
| Other-VS-Normal |
1.287790E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.324499647268E-10 |
| Normal-vs-N1 |
9.67779999472285E-08 |
| N0-vs-N1 |
9.698800E-01 |
|
|
